Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders
暂无分享,去创建一个
[1] T. Klockgether,et al. Creatine has no beneficial effect on skeletal muscle energy metabolism in patients with single mitochondrial DNA deletions: a placebo‐controlled, double‐blind 31P‐MRS crossover study , 2005, European journal of neurology.
[2] N. Chu,et al. Coenzyme Q10 treatment in mitochondrial encephalomyopathies. Short-term double-blind, crossover study. , 1997, European neurology.
[3] A. Straube,et al. A placebo-controlled crossover trial of creatine in mitochondrial diseases , 2000, Neurology.
[4] L. Packer,et al. Comparison of the effect of α-lipoic acid and α-tocopherol supplementation on measures of oxidative stress , 1999 .
[5] A. Rötig. [Mitochondrial cytopathies]. , 1996, Pathologie-biologie.
[6] P. Brugières,et al. Choreic movements and MRI abnormalities in the subthalamic nuclei reversible after administration of coenzyme Q10 and multiple vitamins in a patient with bilateral optic neuropathy , 1999, Movement disorders : official journal of the Movement Disorder Society.
[7] I. MacDonald,et al. Cofactor treatment improves ATP synthetic capacity in patients with oxidative phosphorylation disorders. , 2004, Molecular genetics and metabolism.
[8] M. Tarnopolsky,et al. Effect of alpha-lipoic acid combined with creatine monohydrate on human skeletal muscle creatine and phosphagen concentration. , 2003, International journal of sport nutrition and exercise metabolism.
[9] E Hultman,et al. Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation. , 1992, Clinical science.
[10] A. Boneh,et al. Effect of high-dose vitamins, coenzyme Q and high-fat diet in paediatric patients with mitochondrial diseases , 2004, Journal of Inherited Metabolic Disease.
[11] I. Nonaka,et al. Treatment of mitochondrial encephalomyopathy with a combination of cytochrome C and vitamins B1 and B2 , 1997, Brain and Development.
[12] T. Montine,et al. Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases. , 2004, Chemistry and physics of lipids.
[13] M. Tarnopolsky,et al. Mitochondrial myopathies: diagnosis, exercise intolerance, and treatment options. , 2005, Medicine and science in sports and exercise.
[14] M. Beal,et al. A carbon column-based liquid chromatography electrochemical approach to routine 8-hydroxy-2'-deoxyguanosine measurements in urine and other biologic matrices: a one-year evaluation of methods. , 1999, Free radical biology & medicine.
[15] N. Bresolin,et al. Ubidecarenone in the treatment of mitochondrial myopathies: a multi-center double-blind trial , 1990, Journal of the Neurological Sciences.
[16] M. Tarnopolsky,et al. A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies , 1997, Muscle & nerve.
[17] P. Peterson,et al. The treatment of mitochondrial myopathies and encephalomyopathies. , 1995, Biochimica et biophysica acta.
[18] F. Hanefeld,et al. Effectiveness of creatine monohydrate in mitochondrial encephalomyopathies. , 2003, Pediatric neurology.
[19] J. Haines,et al. Degree of heteroplasmy reflects oxidant damage in a large family with the mitochondrial DNA A8344G mutation. , 2005, Free radical biology & medicine.
[20] M. Tarnopolsky,et al. Direct measurement of high‐energy phosphate compounds in patients with neuromuscular disease , 1999, Muscle & nerve.
[21] M. Tarnopolsky,et al. Creatine monohydrate enhances strength and body composition in Duchenne muscular dystrophy , 2004, Neurology.
[22] M. Tarnopolsky,et al. Nutritional and exercise-based therapies in the treatment of mitochondrial disease , 2002, Current opinion in clinical nutrition and metabolic care.
[23] Gianni Parise,et al. Creatine supplementation enhances isometric strength and body composition improvements following strength exercise training in older adults. , 2003, The journals of gerontology. Series A, Biological sciences and medical sciences.
[24] M. Widlansky,et al. Lipoic acid as a potential therapy for chronic diseases associated with oxidative stress. , 2004, Current medicinal chemistry.
[25] G. Siciliano,et al. Long-term treatment with idebenone and riboflavin in a patient with MELAS , 2000, Neurological Sciences.
[26] P. Matthews,et al. Coenzyme Q10 with multiple vitamins is generally ineffective in treatment of mitochondrial disease , 1993, Neurology.
[27] R. Artuch,et al. Biochemical monitoring of the treatment in paediatric patients with mitochondrial disease , 1998, Journal of Inherited Metabolic Disease.
[28] P. Montuschi,et al. Isoprostanes: markers and mediators of oxidative stress , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[29] P. Bénit,et al. Coenzyme Q(10) and idebenone in the therapy of respiratory chain diseases: rationale and comparative benefits. , 2002, Molecular genetics and metabolism.
[30] D. Glerum,et al. Nutritional cofactor treatment in mitochondrial disorders. , 2003, Journal of the American Dietetic Association.
[31] M. Beal,et al. Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disorders , 2001, Annals of neurology.
[32] P. Sestili,et al. Creatine supplementation affords cytoprotection in oxidatively injured cultured mammalian cells via direct antioxidant activity. , 2006, Free radical biology & medicine.
[33] M. Tarnopolsky,et al. Creatine monohydrate increases strength in patients with neuromuscular disease , 1999, Neurology.
[34] J. Morrow,et al. F2-Isoprostanes as markers of oxidative stress in vivo: An overview , 2005, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[35] A. M. Salio,et al. Coenzyme Q 10 Improves Lactic Acidosis, Strokelike Episodes, and Epilepsy in a Patient With MELAS (Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Strokelike episodes) , 2004, Clinical neuropharmacology.
[36] Yau-Huei Wei,et al. Increased 8-hydroxy-2'-deoxyguanosine in leukocyte DNA in Leber's hereditary optic neuropathy. , 2004, Investigative ophthalmology & visual science.
[37] L. Migliore,et al. Evaluation of cytogenetic and DNA damage in mitochondrial disease patients: effects of coenzyme Q10 therapy. , 2004, Mutagenesis.
[38] J. Lawler,et al. Direct antioxidant properties of creatine. , 2002, Biochemical and biophysical research communications.
[39] M. Tarnopolsky,et al. Patients with dystrophinopathy show evidence of increased oxidative stress. , 2003, Free radical biology & medicine.